N‐Dihydrogalactochitosan Drives Conventional and Alternative Activations of STING to Synergize Type I IFN and IL‐1β Productions for Antitumor Immunity von Hoover, Ashley R., Liu, Kaili, Furrer, Coline, Lam, Samuel Siu Kit, Anderson, David W., Zhou, Zhijun, Yang, Jingxuan, Wong, Chun Fung, Medcalf, Alexandra D., Sun, Xiao‐Hong, Hode, Tomas, Alleruzzo, Lu, Delawder, Abby, Raker, Joseph, Abousleiman, Ghainaa, Valerio, Trisha I., Sun, Yuanhong, Papin, James F., Li, Min, Chen, Wei R.

Volltext